163 related articles for article (PubMed ID: 16614620)
1. [Indications for intravenous immunoglobulins].
Mouthon L
Presse Med; 2006 Apr; 35(4 Pt 2):714-9. PubMed ID: 16614620
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
Daoud YJ; Amin KG
Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
[TBL] [Abstract][Full Text] [Related]
3. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
Abinun M; Cant AJ
Lancet; 1994 Jan; 343(8892):300. PubMed ID: 7905129
[No Abstract] [Full Text] [Related]
4. Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review.
Perez CM; Kubak BM; Cryer HG; Salehmugodam S; Vespa P; Farmer D
Am J Med; 1997 Jan; 102(1):111-3. PubMed ID: 9209207
[No Abstract] [Full Text] [Related]
5. Immune supplementation and immune modulation with intravenous immunoglobulin.
Mazer BD; Al-Tamemi S; Yu JW; Hamid Q
J Allergy Clin Immunol; 2005 Oct; 116(4):941-4. PubMed ID: 16210080
[No Abstract] [Full Text] [Related]
6. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients.
Norrby-Teglund A; Low DE; McGeer A; Kotb M
Adv Exp Med Biol; 1997; 418():563-6. PubMed ID: 9331714
[No Abstract] [Full Text] [Related]
7. Dilemmas in the treatment of invasive Streptococcus pyogenes infections.
Stevens DL
Clin Infect Dis; 2003 Aug; 37(3):341-3. PubMed ID: 12884157
[No Abstract] [Full Text] [Related]
8. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses.
Schlievert PM
J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S107-10. PubMed ID: 11586276
[TBL] [Abstract][Full Text] [Related]
9. [Polyvalent intravenous immunoglobulins: their use in dermatology].
Derancourt C; Humbert P; Agache P
Ann Dermatol Venereol; 1992; 119(6-7):487-8. PubMed ID: 1444110
[No Abstract] [Full Text] [Related]
10. Clinicopathological conference: multisystem failure in a child.
Chan L; Chinnock B
Acad Emerg Med; 2000 Feb; 7(2):169-73. PubMed ID: 10691076
[No Abstract] [Full Text] [Related]
11. The role of intravenous immunoglobulins in pediatric diseases.
Ramasubramanian KV; Kumar A; Kabra SK; Seth V
Indian Pediatr; 1999 Jan; 36(1):51-63. PubMed ID: 10709123
[No Abstract] [Full Text] [Related]
12. Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review.
Lamothe F; D'Amico P; Ghosn P; Tremblay C; Braidy J; Patenaude JV
Clin Infect Dis; 1995 Dec; 21(6):1469-70. PubMed ID: 8749635
[TBL] [Abstract][Full Text] [Related]
13. Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome.
Stevens DL
Clin Infect Dis; 1998 Mar; 26(3):639-41. PubMed ID: 9524836
[No Abstract] [Full Text] [Related]
14. High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders.
Jolles S
Clin Exp Immunol; 2002 Sep; 129(3):385-9. PubMed ID: 12197877
[No Abstract] [Full Text] [Related]
15. Efficacy of polyspecific intravenous immunoglobulin therapy in streptococcal toxic shock syndrome.
Arends JE; Harkisoen S
Clin Infect Dis; 2015 Jan; 60(2):324. PubMed ID: 25313253
[No Abstract] [Full Text] [Related]
16. Use of intravenous immunoglobulin therapy in autoimmune blistering diseases.
Ahmed AR
Int Immunopharmacol; 2006 Apr; 6(4):557-78. PubMed ID: 16504919
[TBL] [Abstract][Full Text] [Related]
17. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
Darenberg J; Söderquist B; Normark BH; Norrby-Teglund A
Clin Infect Dis; 2004 Mar; 38(6):836-42. PubMed ID: 14999628
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA; Raphaël JC; Swan AV; van Doorn PA
Cochrane Database Syst Rev; 2001; (2):CD002063. PubMed ID: 11406030
[TBL] [Abstract][Full Text] [Related]
19. T cell activation and cytokine release in streptococcal toxic shock-like syndrome.
Nadal D; Lauener RP; Braegger CP; Kaufhold A; Simma B; Lütticken R; Seger RA
J Pediatr; 1993 May; 122(5 Pt 1):727-9. PubMed ID: 8496751
[TBL] [Abstract][Full Text] [Related]
20. [Is intravenous administration of immunoglobulins a first-choice method in autoimmune diseases?].
Vermeulen M
Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1955-8. PubMed ID: 8413702
[No Abstract] [Full Text] [Related]
[Next] [New Search]
